0001144204-18-034454.txt : 20180615
0001144204-18-034454.hdr.sgml : 20180615
20180615172225
ACCESSION NUMBER: 0001144204-18-034454
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180614
FILED AS OF DATE: 20180615
DATE AS OF CHANGE: 20180615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SALZMAN BARRY M
CENTRAL INDEX KEY: 0001432179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38128
FILM NUMBER: 18903081
MAIL ADDRESS:
STREET 1: 464 COMMON STREET
STREET 2: SUITE 301
CITY: BELMONT
STATE: MA
ZIP: 02478
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc.
CENTRAL INDEX KEY: 0001651407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472568632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 212-554-4366
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
tv496606_form4.xml
FORM 4
X0306
4
2018-06-14
0
0001651407
Checkpoint Therapeutics, Inc.
CKPT
0001432179
SALZMAN BARRY M
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
1
0
0
0
COMMON STOCK
2018-06-14
4
A
0
16448
0.00
A
76448
D
The 16,448 shares of restricted Common Stock will vest on June 14, 2021, subject to Mr. Salzman's continued service on the board on such date.
Represents shares of restricted Common Stock which vest over various time periods.
/s/ James F. Oliviero, Attorney-in-Fact
2018-06-15